USP Draft Medicare Formulary Sets 146 Drug Categories And Classes
This article was originally published in The Pink Sheet Daily
Executive Summary
The proposed total is greater than the number of classes desired by PBMs but falls below the threshold drug manufacturers are seeking. Medicare Part D plans following the model formulary would have to offer at least two drugs in each therapeutic category and pharmacologic class.
You may also be interested in...
Medicare Formularies Need One Of Each USP “Key Drug Type,” CMS Says
The Centers for Medicare & Medicaid Services expects Medicare prescription drug plan formularies to include at least one drug from each of U.S. Pharmacopeia's "formulary key drug types" list
Medicare Formularies Need One Of Each USP “Key Drug Type,” CMS Says
The Centers for Medicare & Medicaid Services expects Medicare prescription drug plan formularies to include at least one drug from each of U.S. Pharmacopeia's "formulary key drug types" list
USP's Finalized Model For Medicare Rx Formularies Retains 146 Drug Groups
Overall, the model guidelines resemble the version proposed by USP in August but include revisions to specific therapeutic categories and pharmacologic classes. Proton pump inhibitors are placed in a separate drug class; SSRIs/SNRIs remain off the formal chart.